Transcriptomic and metabolomic analyses reveal the spatial role of carnitine metabolism in the progression of hepatitis B virus cirrhosis to hepatocellular carcinoma
Liver cirrhosis (LC) and hepatocellular carcinoma (HCC) resulting from chronic hepatitis B virus (HBV) infection are major health concerns. Identifying critical biomarkers and molecular targets is needed for early diagnosis, prognosis, and therapy of these diseases. In this study, we explored the ge...
Uloženo v:
| Vydáno v: | Frontiers in microbiology Ročník 15; s. 1461456 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
Frontiers Media S.A
2024
|
| Témata: | |
| ISSN: | 1664-302X, 1664-302X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Liver cirrhosis (LC) and hepatocellular carcinoma (HCC) resulting from chronic hepatitis B virus (HBV) infection are major health concerns. Identifying critical biomarkers and molecular targets is needed for early diagnosis, prognosis, and therapy of these diseases.
In this study, we explored the gene expression and metabolism in the liver tissues of LC, HCC, and healthy controls, to analyse and identify potential biomarkers of disease progression. Mass spectrometry imaging was used to evaluate the spatial distribution of key metabolites.
The results revealed significant changes in gene expression and metabolic pathways along with disease progression. The upregulated genes were associated with extracellular matrix remodeling and cancer pathways, including LAMC1-3, COL9A2, COL1A1, MYL9, MYH11, and KAT2A. The downregulated genes were linked to immune response and fatty acid metabolism. Metabolomic analysis showed major changes in lipid and choline metabolism. Consistent changes in the expression of specific genes and metabolites were correlated with clinical data. Notably, metabolites such as L-acetylcarnitine, histamine, and 4-trimethylammoniobutanoic acid demonstrated high accuracy (AUC > 0.85) in distinguishing between healthy, LC, and HCC groups. This study identifies key gene and metabolite changes in HBV related LC and HCC, highlighting critical pathways involved in disease progression. Biomarkers like L-acetylcarnitine and KAT2A show promise for early diagnosis and prognosis, potentially improving outcomes for hepatitis liver disease patients. |
|---|---|
| AbstractList | Liver cirrhosis (LC) and hepatocellular carcinoma (HCC) resulting from chronic hepatitis B virus (HBV) infection are major health concerns. Identifying critical biomarkers and molecular targets is needed for early diagnosis, prognosis, and therapy of these diseases.
In this study, we explored the gene expression and metabolism in the liver tissues of LC, HCC, and healthy controls, to analyse and identify potential biomarkers of disease progression. Mass spectrometry imaging was used to evaluate the spatial distribution of key metabolites.
The results revealed significant changes in gene expression and metabolic pathways along with disease progression. The upregulated genes were associated with extracellular matrix remodeling and cancer pathways, including LAMC1-3, COL9A2, COL1A1, MYL9, MYH11, and KAT2A. The downregulated genes were linked to immune response and fatty acid metabolism. Metabolomic analysis showed major changes in lipid and choline metabolism. Consistent changes in the expression of specific genes and metabolites were correlated with clinical data. Notably, metabolites such as L-acetylcarnitine, histamine, and 4-trimethylammoniobutanoic acid demonstrated high accuracy (AUC > 0.85) in distinguishing between healthy, LC, and HCC groups. This study identifies key gene and metabolite changes in HBV related LC and HCC, highlighting critical pathways involved in disease progression. Biomarkers like L-acetylcarnitine and KAT2A show promise for early diagnosis and prognosis, potentially improving outcomes for hepatitis liver disease patients. Liver cirrhosis (LC) and hepatocellular carcinoma (HCC) resulting from chronic hepatitis B virus (HBV) infection are major health concerns. Identifying critical biomarkers and molecular targets is needed for early diagnosis, prognosis, and therapy of these diseases.IntroductionLiver cirrhosis (LC) and hepatocellular carcinoma (HCC) resulting from chronic hepatitis B virus (HBV) infection are major health concerns. Identifying critical biomarkers and molecular targets is needed for early diagnosis, prognosis, and therapy of these diseases.In this study, we explored the gene expression and metabolism in the liver tissues of LC, HCC, and healthy controls, to analyse and identify potential biomarkers of disease progression. Mass spectrometry imaging was used to evaluate the spatial distribution of key metabolites.MethodsIn this study, we explored the gene expression and metabolism in the liver tissues of LC, HCC, and healthy controls, to analyse and identify potential biomarkers of disease progression. Mass spectrometry imaging was used to evaluate the spatial distribution of key metabolites.The results revealed significant changes in gene expression and metabolic pathways along with disease progression. The upregulated genes were associated with extracellular matrix remodeling and cancer pathways, including LAMC1-3, COL9A2, COL1A1, MYL9, MYH11, and KAT2A. The downregulated genes were linked to immune response and fatty acid metabolism. Metabolomic analysis showed major changes in lipid and choline metabolism. Consistent changes in the expression of specific genes and metabolites were correlated with clinical data. Notably, metabolites such as L-acetylcarnitine, histamine, and 4-trimethylammoniobutanoic acid demonstrated high accuracy (AUC > 0.85) in distinguishing between healthy, LC, and HCC groups. This study identifies key gene and metabolite changes in HBV related LC and HCC, highlighting critical pathways involved in disease progression. Biomarkers like L-acetylcarnitine and KAT2A show promise for early diagnosis and prognosis, potentially improving outcomes for hepatitis liver disease patients.Results and discussionThe results revealed significant changes in gene expression and metabolic pathways along with disease progression. The upregulated genes were associated with extracellular matrix remodeling and cancer pathways, including LAMC1-3, COL9A2, COL1A1, MYL9, MYH11, and KAT2A. The downregulated genes were linked to immune response and fatty acid metabolism. Metabolomic analysis showed major changes in lipid and choline metabolism. Consistent changes in the expression of specific genes and metabolites were correlated with clinical data. Notably, metabolites such as L-acetylcarnitine, histamine, and 4-trimethylammoniobutanoic acid demonstrated high accuracy (AUC > 0.85) in distinguishing between healthy, LC, and HCC groups. This study identifies key gene and metabolite changes in HBV related LC and HCC, highlighting critical pathways involved in disease progression. Biomarkers like L-acetylcarnitine and KAT2A show promise for early diagnosis and prognosis, potentially improving outcomes for hepatitis liver disease patients. IntroductionLiver cirrhosis (LC) and hepatocellular carcinoma (HCC) resulting from chronic hepatitis B virus (HBV) infection are major health concerns. Identifying critical biomarkers and molecular targets is needed for early diagnosis, prognosis, and therapy of these diseases.MethodsIn this study, we explored the gene expression and metabolism in the liver tissues of LC, HCC, and healthy controls, to analyse and identify potential biomarkers of disease progression. Mass spectrometry imaging was used to evaluate the spatial distribution of key metabolites.Results and discussionThe results revealed significant changes in gene expression and metabolic pathways along with disease progression. The upregulated genes were associated with extracellular matrix remodeling and cancer pathways, including LAMC1-3, COL9A2, COL1A1, MYL9, MYH11, and KAT2A. The downregulated genes were linked to immune response and fatty acid metabolism. Metabolomic analysis showed major changes in lipid and choline metabolism. Consistent changes in the expression of specific genes and metabolites were correlated with clinical data. Notably, metabolites such as L-acetylcarnitine, histamine, and 4-trimethylammoniobutanoic acid demonstrated high accuracy (AUC > 0.85) in distinguishing between healthy, LC, and HCC groups. This study identifies key gene and metabolite changes in HBV related LC and HCC, highlighting critical pathways involved in disease progression. Biomarkers like L-acetylcarnitine and KAT2A show promise for early diagnosis and prognosis, potentially improving outcomes for hepatitis liver disease patients. |
| Author | Gao, Pengxiang Pu, Wenjun Luo, Ziye Liu, Qiuping |
| Author_xml | – sequence: 1 givenname: Pengxiang surname: Gao fullname: Gao, Pengxiang – sequence: 2 givenname: Qiuping surname: Liu fullname: Liu, Qiuping – sequence: 3 givenname: Ziye surname: Luo fullname: Luo, Ziye – sequence: 4 givenname: Wenjun surname: Pu fullname: Pu, Wenjun |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39735192$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNks1uGyEQx1GVqEnTvEAPFcde7PLt3WMbNW2kSL0kUm-IZYeYiAUX2Eh5oL5nWNuJygFmht_8GWA-oJOYIiD0iZI1513_1U3eDmtGmFhToaiQ6h06p0qJFSfsz8l_9hm6LOWRtCEIa_N7dMb7DZe0Z-fo3102sdjsdzU1RWziiCeoZkjh6JvwXKDgDE9gAq5bwGVnqm92TgFwctiaHH31EV4zfZmwj3t2l9NDhlJ8igu6hSW3-oK_4yef54Ktz3mbSovUdNhOFkKYg8mLsPUxTeYjOnUmFLg8rhfo_vrH3dWv1e3vnzdX325XlitRV1Iw6Kmlzo1KUpBEgABQzets75zkAqgkG8UGypTowXROuAGoBcl6NXJ-gW4OumMyj3qX_WTys07G630g5QdtcvU2gN4MTg3SMmaIEx23xlEm6dC5Dhx3ZNH6ctBqT_B3hlL15MtyNRMhzUXzVgptZUvV0M9HdB4mGN8Ofv2mBrADYHMqJYN7QyjRSzvofTvopR30sR34C9tnrSc |
| Cites_doi | 10.3390/genes13101817 10.3390/cancers13205250 10.1097/HC9.0000000000000187 10.3390/cells8121503 10.1038/s41388-018-0298-9 10.1074/jbc.M113.458737 10.1186/s12935-022-02775-9 10.1371/journal.pone.0291798 10.1007/s12672-024-01069-y 10.1007/s12325-022-02416-7 10.1016/j.heliyon.2023.e23867 10.1155/2022/7840606 10.1038/s41568-019-0216-7 10.1371/journal.pone.0130346 10.3727/105221615X14399878166230 10.1016/j.gendis.2023.02.050 10.1038/s41572-020-00240-3 10.1016/j.bpg.2011.02.009 10.3389/fimmu.2021.649197 10.1371/journal.pone.0274544 10.1186/s13578-016-0114-6 10.1038/nri3623 10.1186/s12889-024-17948-6 10.1136/gut.40.4.544 10.18632/oncotarget.19173 10.1007/s10238-013-0262-5 10.2174/1386207326666230717094936 10.3892/mmr.2014.2036 10.3389/fmicb.2021.795388 10.18632/aging.103554 10.1038/s41575-023-00760-9 10.1038/s41575-021-00520-7 10.1002/hep.30508 10.1111/liv.16056 10.1186/s43066-024-00322-x 10.1016/j.aca.2018.02.030 10.1159/000367735 10.3389/fmicb.2022.1080484 |
| ContentType | Journal Article |
| Copyright | Copyright © 2024 Gao, Liu, Luo and Pu. |
| Copyright_xml | – notice: Copyright © 2024 Gao, Liu, Luo and Pu. |
| DBID | AAYXX CITATION NPM 7X8 DOA |
| DOI | 10.3389/fmicb.2024.1461456 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1664-302X |
| ExternalDocumentID | oai_doaj_org_article_7bf6b5c22a0f483caf1251b8f8ef3f03 39735192 10_3389_fmicb_2024_1461456 |
| Genre | Journal Article |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK ECGQY GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 PGMZT RNS RPM ACXDI IAO IEA IHR IPNFZ NPM RIG 7X8 |
| ID | FETCH-LOGICAL-c364t-542e91c1ffd651e504e4ee6fd68c9ff534e150762b12649ea8f4fbe1ce5296d33 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001385337200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1664-302X |
| IngestDate | Fri Oct 03 12:53:13 EDT 2025 Fri Sep 05 12:36:58 EDT 2025 Sun Jan 05 01:57:19 EST 2025 Sat Nov 29 03:10:49 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | mass spectrometry imaging metabolomic carnitine metabolism transcriptomic hepatitis B virus hepatocellular carcinoma liver cirrhosis |
| Language | English |
| License | Copyright © 2024 Gao, Liu, Luo and Pu. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c364t-542e91c1ffd651e504e4ee6fd68c9ff534e150762b12649ea8f4fbe1ce5296d33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/7bf6b5c22a0f483caf1251b8f8ef3f03 |
| PMID | 39735192 |
| PQID | 3150136456 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_7bf6b5c22a0f483caf1251b8f8ef3f03 proquest_miscellaneous_3150136456 pubmed_primary_39735192 crossref_primary_10_3389_fmicb_2024_1461456 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-00-00 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – year: 2024 text: 2024-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in microbiology |
| PublicationTitleAlternate | Front Microbiol |
| PublicationYear | 2024 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Lin (B21) 2022; 13 Hsu (B18) 2023; 20 Pu (B28) 2023; 7 Toyoda (B32) 2015; 4 Gajos-Michniewicz (B10) 2024; 11 Yang (B36) 2022; 13 Cai (B3) 2020; 12 Yin (B37) 2015; 16 Chen (B5) 2013; 288 Albillos (B2) 2022; 19 Chen (B4) 2023; 40 Zhao (B38) 2018; 37 Chrostek (B7) 2014; 14 Wu (B33) 2024; 10 Wu (B34) 2024; 24 Gu (B12) 2021; 12 Pellicoro (B26) 2014; 14 Cheng (B6) 2024; 15 Qin (B29) 2022; 12 Hoxhaj (B17) 2020; 20 Pinzani (B27) 2011; 25 Xie (B35) 2022; 2022 Fan (B9) 2021; 13 Meikle (B24) 2015; 10 Schwarz (B30) 2024; 44 Majaz (B23) 2016; 6 Abbass (B1) 2024; 14 Gong (B11) 2017; 8 Llovet (B22) 2021; 7 He (B14) 2022; 22 Kuang (B19) 2024; 27 Thorgersen (B31) 2019; 70 He (B13) 2018; 1015 Hintermann (B15) 2019; 8 Liang (B20) 2023; 18 Cui (B8) 2014; 9 Nartey (B25) 2022; 17 Homann (B16) 1997; 40 |
| References_xml | – volume: 13 start-page: 1817 year: 2022 ident: B21 article-title: KAT2A/E2F1 promotes cell proliferation and migration via upregulationg the exression of UBE2C in pan-cancer publication-title: Genes doi: 10.3390/genes13101817 – volume: 13 start-page: 5250 year: 2021 ident: B9 article-title: Metabolism-associated epigenetic and immunoepigenetic reprogramming in liver cancer publication-title: Cancers doi: 10.3390/cancers13205250 – volume: 7 start-page: 187 year: 2023 ident: B28 article-title: Dysregulation of lipid metabolism in the pseudolobule promotes region-specific autophagy in hepatitis B liver cirrhosis publication-title: Hepatol. Commun. doi: 10.1097/HC9.0000000000000187 – volume: 8 start-page: 1503 year: 2019 ident: B15 article-title: The many roles of cell adhesion molecules in hepatic fibrosis publication-title: Cells doi: 10.3390/cells8121503 – volume: 37 start-page: 4821 year: 2018 ident: B38 article-title: C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation publication-title: Oncogene doi: 10.1038/s41388-018-0298-9 – volume: 288 start-page: 14510 year: 2013 ident: B5 article-title: Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.458737 – volume: 22 start-page: 366 year: 2022 ident: B14 article-title: Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression publication-title: Cancer Cell Int. doi: 10.1186/s12935-022-02775-9 – volume: 18 start-page: e0291798 year: 2023 ident: B20 article-title: Comprehensive metabolomics and transcriptomics analysis reveals protein and amino acid metabolic characteristics in liver tissue under chronic hypoxia publication-title: PLoS ONE doi: 10.1371/journal.pone.0291798 – volume: 15 start-page: 206 year: 2024 ident: B6 article-title: Role of lipid metabolism in hepatocellular carcinoma publication-title: Discov. Oncol. doi: 10.1007/s12672-024-01069-y – volume: 40 start-page: 1171 year: 2023 ident: B4 article-title: Complement C3 facilitates stratification of stages of chronic hepatitis b and signifies development of acute-on-chronic liver failure in acute decompensated cirrhosis publication-title: Adv. Ther. doi: 10.1007/s12325-022-02416-7 – volume: 10 start-page: e23867 year: 2024 ident: B33 article-title: The role of serum acylcarnitine profiling for the detection of multiple solid tumors in humans publication-title: Heliyon doi: 10.1016/j.heliyon.2023.e23867 – volume: 2022 start-page: 7840606 year: 2022 ident: B35 article-title: Circulating metabolic markers related to the diagnosis of hepatocellular carcinoma publication-title: J. Oncol. doi: 10.1155/2022/7840606 – volume: 20 start-page: 74 year: 2020 ident: B17 article-title: The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-019-0216-7 – volume: 10 start-page: e0130346 year: 2015 ident: B24 article-title: Circulating lipids are associated with alcoholic liver cirrhosis and represent potential biomarkers for risk assessment publication-title: PLoS ONE doi: 10.1371/journal.pone.0130346 – volume: 16 start-page: 187 year: 2015 ident: B37 article-title: The histone acetyltransferase GCN5 expression is elevated and regulated by c-Myc and E2F1 transcription factors in human colon cancer publication-title: Gene Expr. doi: 10.3727/105221615X14399878166230 – volume: 11 start-page: 727 year: 2024 ident: B10 article-title: WNT/beta-catenin signaling in hepatocellular carcinoma: the aberrant activation, pathogenic roles, and therapeutic opportunities publication-title: Genes Dis. doi: 10.1016/j.gendis.2023.02.050 – volume: 7 start-page: 6 year: 2021 ident: B22 article-title: Hepatocellular carcinoma publication-title: Nat. Rev. Dis. Prim. doi: 10.1038/s41572-020-00240-3 – volume: 25 start-page: 281 year: 2011 ident: B27 article-title: Liver cirrhosis publication-title: Best Pract. Res. Clin. Gastroenterol. doi: 10.1016/j.bpg.2011.02.009 – volume: 12 start-page: 649197 year: 2021 ident: B12 article-title: High L-carnitine levels impede viral control in chronic hepatitis B virus infection publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.649197 – volume: 17 start-page: e0274544 year: 2022 ident: B25 article-title: Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival publication-title: PLoS ONE doi: 10.1371/journal.pone.0274544 – volume: 6 start-page: 47 year: 2016 ident: B23 article-title: Histone acetyl transferase GCN5 promotes human hepatocellular carcinoma progression by enhancing AIB1 expression publication-title: Cell Biosci. doi: 10.1186/s13578-016-0114-6 – volume: 14 start-page: 181 year: 2014 ident: B26 article-title: Liver fibrosis and repair: immune regulation of wound healing in a solid organ publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3623 – volume: 24 start-page: 363 year: 2024 ident: B34 article-title: Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019 publication-title: BMC Public Health doi: 10.1186/s12889-024-17948-6 – volume: 40 start-page: 544 year: 1997 ident: B16 article-title: Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality publication-title: Gut doi: 10.1136/gut.40.4.544 – volume: 8 start-page: 63890 year: 2017 ident: B11 article-title: Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis publication-title: Oncotarget doi: 10.18632/oncotarget.19173 – volume: 14 start-page: 417 year: 2014 ident: B7 article-title: The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins publication-title: Clin. Exp. Med. doi: 10.1007/s10238-013-0262-5 – volume: 27 start-page: 922 year: 2024 ident: B19 article-title: Transcriptomic and metabolomic analysis of liver cirrhosis publication-title: Comb. Chem. High Throughput Screen. doi: 10.2174/1386207326666230717094936 – volume: 9 start-page: 1641 year: 2014 ident: B8 article-title: F-actin cytoskeleton reorganization is associated with hepatic stellate cell activation publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2014.2036 – volume: 12 start-page: 795388 year: 2022 ident: B29 article-title: KAT2A promotes hepatitis B virus transcription and replication through epigenetic regulation of cccDNA minichromosome publication-title: Front. Microbiol. doi: 10.3389/fmicb.2021.795388 – volume: 12 start-page: 14949 year: 2020 ident: B3 article-title: Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma publication-title: Aging doi: 10.18632/aging.103554 – volume: 20 start-page: 524 year: 2023 ident: B18 article-title: Global burden of hepatitis B virus: current status, missed opportunities and a call for action publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-023-00760-9 – volume: 19 start-page: 112 year: 2022 ident: B2 article-title: Cirrhosis-associated immune dysfunction publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-021-00520-7 – volume: 70 start-page: 725 year: 2019 ident: B31 article-title: The role of complement in liver injury, regeneration, and transplantation publication-title: Hepatology doi: 10.1002/hep.30508 – volume: 44 start-page: 2904 year: 2024 ident: B30 article-title: High histamine levels are associated with acute-on-chronic liver failure and liver-related death in patients with advanced chronic liver disease publication-title: Liver Int. doi: 10.1111/liv.16056 – volume: 14 start-page: 19 year: 2024 ident: B1 article-title: Exploring the prognostic significance of blood carnitine and acylcarnitines in hepatitis C virus-induced hepatocellular carcinoma publication-title: Egypt. Liver J. doi: 10.1186/s43066-024-00322-x – volume: 1015 start-page: 50 year: 2018 ident: B13 article-title: MassImager: a software for interactive and in-depth analysis of mass spectrometry imaging data publication-title: Anal. Chim. Acta doi: 10.1016/j.aca.2018.02.030 – volume: 4 start-page: 126 year: 2015 ident: B32 article-title: Tumor markers for hepatocellular carcinoma: simple and significant predictors of outcome in patients with HCC publication-title: Liver Cancer doi: 10.1159/000367735 – volume: 13 start-page: 1080484 year: 2022 ident: B36 article-title: Human liver tissue transcriptomics revealed immunometabolic disturbances and related biomarkers in hepatitis B virus-related acute-on-chronic liver failure publication-title: Front. Microbiol. doi: 10.3389/fmicb.2022.1080484 |
| SSID | ssj0000402000 |
| Score | 2.3680577 |
| Snippet | Liver cirrhosis (LC) and hepatocellular carcinoma (HCC) resulting from chronic hepatitis B virus (HBV) infection are major health concerns. Identifying... IntroductionLiver cirrhosis (LC) and hepatocellular carcinoma (HCC) resulting from chronic hepatitis B virus (HBV) infection are major health concerns.... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database |
| StartPage | 1461456 |
| SubjectTerms | hepatitis B virus hepatocellular carcinoma liver cirrhosis mass spectrometry imaging metabolomic transcriptomic |
| Title | Transcriptomic and metabolomic analyses reveal the spatial role of carnitine metabolism in the progression of hepatitis B virus cirrhosis to hepatocellular carcinoma |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39735192 https://www.proquest.com/docview/3150136456 https://doaj.org/article/7bf6b5c22a0f483caf1251b8f8ef3f03 |
| Volume | 15 |
| WOSCitedRecordID | wos001385337200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1664-302X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000402000 issn: 1664-302X databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center) customDbUrl: eissn: 1664-302X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000402000 issn: 1664-302X databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagAokL4s0WqIzEDUWsY-d1pKgVB6g4ANqb5dgzaiQ2QUm2Ehf-Df-zM3a22gviwiFR4tix48-PGXvyjRBvHOqAQWNmKqgyAzQOOigVnbAJdOhEVv39U3VxUW82zZcDV19sE5bogVPFvataLNvC57lbo6m1d8hTcltjDagx8XyS1HOgTMUxmNWi9Tr9JUNaWEMwdb4lfTA3PDgowx6rD2aiSNj_dykzzjbnD8T9RUyU71PxHopb0D8Sd5PjyF-PxZ84xcQOz38VS9cHuYWZAP2x3DPVCEySCZroPSTlyYltp-ma7QnlgNLzmshMQuY-ZTdtZdfHuNFqKzF2cNRL4LRzN8lTedWNu0n6bhwvh4lC5iE9HngLgG1a-cW-64eteyK-nZ99_fAxWxwuZF6XZs4Kk0OjvEIMZaGgWBswACXd1b5BLDRhSfJjmbeK5KgGXI0GW1AeePc2aP1UHPVDD8-F1BWq4HMVqpx3jAuncxri26JtsdZQh5V4u698-zPxaljSRxgqG6GyDJVdoFqJU8bnJiZzYscAail2aSn2Xy1lJV7v0bXUh7hWXA_DbrKavkrxfixl9CzBfpMVyWvswzA__h9FeCHu8WelJZyX4mged_BK3PFXhOB4Im5Xm_okNmQ6f_59dg0ri_4b |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcriptomic+and+metabolomic+analyses+reveal+the+spatial+role+of+carnitine+metabolism+in+the+progression+of+hepatitis+B+virus+cirrhosis+to+hepatocellular+carcinoma&rft.jtitle=Frontiers+in+microbiology&rft.au=Gao%2C+Pengxiang&rft.au=Liu%2C+Qiuping&rft.au=Luo%2C+Ziye&rft.au=Pu%2C+Wenjun&rft.date=2024&rft.issn=1664-302X&rft.eissn=1664-302X&rft.volume=15&rft_id=info:doi/10.3389%2Ffmicb.2024.1461456&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fmicb_2024_1461456 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon |